PHYTOTECH THERAPEUTICS
PhytoTech has developed advanced oral delivery formulations for cannabinoid-based prescription drugs and holds an exclusive worldwide licensing agreement with Yissum Research Development Company, the commercial arm of the University of Jerusalem, for a proprietary lipid Nano technology.
PHYTOTECH THERAPEUTICS
Industry:
Biotechnology Cannabis Health Care Pharmaceutical
Founded:
2014-01-01
Address:
Sydney, New South Wales, Australia
Country:
Australia
Status:
Active
Similar Organizations
Beryllium Discovery
Beryllium Discovery is a specialized drug discovery contract research organization (CRO), provides research services.
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Foldscope
Foldscope has developed a magnification of 140X and 2-micron resolution
Green Sky Labs
Green Sky Labs develops innovative technologies that enhance the quality of plant cultivation and cannabinoid medicines development.
Hanway Associates
Hanway Associates is a strategy and corporate advisory for the cannabis sector.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Epsilon Healthcare
Epsilon Healthcare focused on the manufacturing and distribution of hydroponics equipment, materials and nutrients.
More informations about "PhytoTech Therapeutics"
Harvest One Completes Acquisition of Israeli-based Phytotech …
Nov 20, 2018 Founded in 2014, Phytotech has developed advanced oral delivery formulations for cannabinoid-based prescription drugs and holds an exclusive worldwide licensing …See details»
Delivra Health Brands - 2018
Jun 25, 2018 Harvest One Cannabis Inc. (TSXV:HVT) ("Harvest One" or the "Company") has signed a binding Share Sale Agreement (“SSA”) with Australian-based MMJ PhytoTech …See details»
PhytoTech Therapeutics - PitchBook
PhytoTech Therapeutics was acquired by Delivra Health Brands. Data Transparency. Meet our data hygiene team. Discover how our experts ensure you’re getting the most accurate financial …See details»
PhytoTech Medical Limited and Canadian MMJ
PhytoTech Therapeutics Ltd., PYL’s wholly owned Israel-based subsidiary, intends to immediately engage in the clinical testing of safety and bioavailability of this pill for the purpose of …See details»
PhytoTech Therapeutics - Products, Competitors, Financials, …
Nov 21, 2018 PhytoTech Therapeutics has developed advanced oral delivery systems for cannabinoid-based prescription drugs and holds an exclusive global licensing agreement for a …See details»
Harvest One Enters Pharmaceutical Market via …
Jun 25, 2018 Andreas Gedeon, Managing Director and CEO of Harvest One, said: "The acquisition of PhytoTech Therapeutics marks an important strategic step in the further refinement of Satipharm as the Group's ...See details»
Harvest One Cannabis Inc. Completes Phytotech Therapeutics Ltd ...
Tel Aviv, Israel Nov 30, 2018 (Issuewire.com) - Harvest One Cannabis Inc. (TSXV: HVT) has revealed that the acquisition of Phytotech Therapeutics Ltd. from MMJ Group Holdings Ltd. …See details»
PhytoTech Therapeutics Ltd. - Drug pipelines, Patents, Clinical …
Explore PhytoTech Therapeutics Ltd. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials.See details»
PhytoTech Therapeutics acquired by Harvest One Cannabis Inc.
Jun 25, 2018 PhytoTech Therapeutics PhytoTech Therapeutics has developed advanced oral delivery formulations for cannabinoid-based prescription drugs. Acquiring Organization: …See details»
Harvest One acquires Phytotech Therapeutics from …
Nov 21, 2018 Harvest One acquires Phytotech Therapeutics from MMJ Group Holdings for $1 million, shares. PTL was further responsible for administrating the successful clinical trials, both Phases 1 and 2, using Satipharm’s proprietary …See details»
MMJ Completes Sale of Phytotech Therapeutics Limited
Nov 21, 2018 /CNW/ - MMJ Group Holdings Limited (ASX: MMJ) ("MMJ" or the "Company") today confirms that it has closed its previously announced sale of 100% of the issued...See details»
PhytoTech Medical Ltd (ASX:PYL) MMJ Merger And Capital
Jul 28, 2015 PhytoTech Therapeutics is the Israeli based subsidiary of MMJ PhytoTech. Through its partnership with Yissum Research Development Company of the Hebrew …See details»
PhytoTech Therapeutics Ltd - Company Profile and News
Company profile page for PhytoTech Therapeutics Ltd including stock price, company news, executives, board members, and contact informationSee details»
PhytoTech Therapeutics Limited Management Changes
PhytoTech Therapeutics Limited ... experienced Contract Research Organization, PTL’s requirement for a full-time CEO has been reduced and as such, Ms. Harvey will oversee daily …See details»
Cannabidiol/tetrahydrocannabinol - PhytoTech Therapeutics
25 Dec 2016 PhytoTech Therapeutics plans a phase II trial for Multiple sclerosis in Israel (NCT03005119) You need to be a logged in or subscribed to view this content Request demo …See details»
Harvest One Completes Acquisition of Israeli-based Phytotech …
Nov 20, 2018 Harvest One (TSXV:HVT) (“Harvest One” or the “Company”) is pleased to announce that it has completed its previously announced acquisition of 100% of Israeli-based …See details»
Cannabidiol - MMJ PhytoTech - AdisInsight - Springer
Feb 22, 2022 Cannabidiol (PTL 101), an oral formulation for the treatment of intractable epilepsy was developed by PhytoTech Therapeutics (subsidiary of MMJ PhytoTech). PTL Cannabidiol - …See details»
PHASE 2 CLINICAL TRIAL FOR TREATMENT OF PEDIATRIC …
MMJ PhytoTech Limited (ASX: MMJ) (“MMJ” or “the Company”) is pleased to advise that its wholly-owned, Israeli-based subsidiary PhytoTech Therapeutics Limited (“PTL”), has …See details»
PhytoTech Labs
PhytoTech Labs: Your global supplier and manufacturer of plant tissue culture production and research chemicals, media, and lab equipment. Our talented sales, customer service, and …See details»
Nutcracker Therapeutics CEO Dr. Igor Khandros Retires as …
2 days ago EMERYVILLE, Calif., March 26, 2025--(BUSINESS WIRE)--Nutcracker Therapeutics, Inc., a contract, research, development and manufacturing organization …See details»